The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab oleh Katherine E.R. Smith, MD, Stephanie L. Pritzl, MD, Wei Yu, PhD, Ilze Bara, MD, Gita Thanarajasingam, MD, Monika D. Kaul, MD, Kirstin A. Williams, PhD, CNP, Amylou C. Dueck, MD, Aaron S. Mansfield, MD